Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections

• US 5,411,857 A
• Filed: 07/16/1992
• Issued: 05/02/1995
• Est. Priority Date: 07/31/1985
• Status: Expired due to Term

• Current Assignee: Roche Molecular Systems (Roche Holding AG)
• Original Assignee: Institut Nationale de La Sante, Institut Pasteur
• Inventors: Kremsdorf, Dina, Beaudenon, Sylvie, Croissant, Odile, Orth, Gerard
• Primary Examiner(s): ZITOMER, STEPHANIE W
• Application Number:
  US07/914,005
• Time in Patent Office: 1,020 Days
• Field of Search: 435/5, 435/6, 435/810, 436/808, 935/78, 536/23.72
• US Class Current: 435/5
• CPC Class Codes: C07K 14/005 from viruses
• CPC Class Codes: C12N 2710/20022 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
• CPC Class Codes: C12Q 1/708 for papilloma
• CPC Class Codes: Y10S 435/81 Packaged device or kit

Abstract

The invention relates to papillomaviruses, particularly to DNA-HPVs isolated from the papillomaviruses IP5 and IP6, the restriction maps of which are presented in FIGS. 10 and 11, and also to probes containing these DNA-HPVs or fragments obtained from them. The invention relates, in addition, to "kits" containing distinct groups of probes, containing one of these DNA-HPVs or DNA-HPV fragments, as well as a procedure for the detection and identification of papillomaviruses which makes use of these different probes.

Claims

1. Isolated DNA of a human papillomavirus (HPV), wherein

said DNA is about 7,000 to about 8,000 base pairs;

and

said DNA is obtained from a virus selected from the group of papillomaviruses consisting of HPV-IP5 and HPV-IP6.

2. A DNA according to claim 1, wherein said DNA encodes a gene of said HPV DNA, and wherein said gene is selected from the group of genes consisting of E1, E6-E7, L1, and L2.

5. Recombinant human papillomavirus (HPV) DNA consisting of DNA according to claim 1.

6. A probe for the detection of human papillomavirus (HPV), said probe consisting of the DNA of claim 1.

3. An isolated DNA fragment, wherein said DNA fragment is obtained by treating HPV-IP5 DNA, or DNA complementary to HPV-IP5 DNA, with at least one restriction enzyme selected from the group consisting of EcoRI, PstI, HindII, PvuII, BamHI, HindIII, KpnI, AveI, and XbaI, and isolating said DNA fragment.

4. An isolated DNA fragment, wherein said DNA fragment is obtained by treating HPV-IP6 DNA, or DNA complementary to HPV-IP6 DNA, with at least one restriction enzyme selected from the group consisting of EcoRI, PstI, HindII, PvuII, BamHI, HindIII, KpnI, AccI, BglII, SepI, EcoRV, and XbaI, and isolating said DNA fragment.

7. The plasmid pSP65/IP5.

8. The plasmid pSP64/IP6.